Comparative study of chromosome aberrations induced with aphidicolin in women affected by breast cancer and cervix uterine cancer.

[1]  R. Mirzayans,et al.  Aphidicolin and 1-beta-D-arabinofuranosylcytosine strongly inhibit transcriptionally active DNA repair in normal human fibroblasts. , 1993, Carcinogenesis.

[2]  M. Santibanez-Koref,et al.  The expression of aphidicolin-induced fragile sites in familial breast cancer patients. , 1993, Cancer genetics and cytogenetics.

[3]  M. Tonato,et al.  Expression of aphidicolin-induced fragile sites in lymphocytes of patients with breast cancer. , 1993, Cancer genetics and cytogenetics.

[4]  Rosenberg Dp.  Dietary fiber, phytoestrogens, and breast cancer. , 1992 .

[5]  C. Baumstark‐Khan.  Effect of aphidicolin on DNA synthesis, PLD-recovery and DNA repair of human diploid fibroblasts. , 1992, International journal of radiation biology.

[6]  M. Inoue,et al.  Detection of Human Papillomavirus Type 16 in Sexual Partners of Patients Having Cervical Cancer by Polymerase Chain Reaction , 1991, Japanese journal of cancer research : Gann.

[7]  P. Vernole,et al.  Fragile site induction by aphidicolin may be increased in parents of neuroblastoma patients. , 1990, Cancer genetics and cytogenetics.

[8]  C. Larsson,et al.  Genomic alterations in human breast carcinomas , 1990, Genes, chromosomes & cancer.

[9]  J. Torhorst,et al.  Cytogenetics of breast cancer. , 1990, Cancer genetics and cytogenetics.

[10]  A. Sandberg.  The chromosomes in human cancer and leukemia , 1990 .

[11]  D. Caporossi,et al.  Common fragile sites and human cancer. A study on lymphocytes from neuroblastoma patients. , 1988, Cancer genetics and cytogenetics.

[12]  C. Sreekantaiah,et al.  Chromosome 1 abnormalities in cervical carcinoma , 1988, Cancer.

[13]  P. Gariglio,et al.  High correlation between molecular alterations of the c-myc oncogene and carcinoma of the uterine cervix. , 1987, Cancer research.

[14]  V. Murty,et al.  Spontaneous chromosomal aberrations in patients with precancerous and cancerous lesions of the cervix uteri. , 1985, Cancer genetics and cytogenetics.

[15]  J. Yunis,et al.  Constitutive fragile sites and cancer. , 1984, Science.

[16]  F. Hecht,et al.  Cancer chromosome breakpoints and common fragile sites induced by aphidicolin. , 1984, Cancer genetics and cytogenetics.

[17]  F. Hecht,et al.  Autosomal fragile sites and cancer. , 1984, American journal of human genetics.

[18]  J. Rowley,et al.  Cancer biology: Heritable fragile sites in cancer , 1984, Nature.

[19]  U. Lönn,et al.  Aphidicolin inhibits the synthesis and joining of short DNA fragments but not the union of 10-kilobase DNA replication intermediates. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[20]  N. B. Atkin,et al.  Nonrandom chromosome changes in carcinoma of the cervix uteri. I. Nine near-diploid tumors. , 1982, Cancer genetics and cytogenetics.

[21]  F. D. Waard,et al.  The epidemiology of breast cancer: review and prospects. , 1969 .